Search
Descriptor English: Fadrozole
Descriptor Spanish: Fadrozol
Descriptor fadrozol
Entry term(s) CGS-16949A
Scope note: Inhibidor selectivo de la aromatasa que es eficaz en el tratamiento de la enfermedad dependiente de estrógenos incluido el cáncer de mama.
Descriptor Portuguese: Fadrozol
Descriptor French: Fadrozole
Entry term(s): CGS-020286A
CGS-16949A
CGS020286A
CGS16949A
Chlorhydrate de fadrozole
FAD-286
FAD286
Tree number(s): D02.626.400
D03.383.129.308.270
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D017316
Scope note: A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer.
Allowable Qualifiers: AA analogues et dérivés
AD administration et posologie
AE effets indésirables
AG agonistes
AI antagonistes et inhibiteurs
AN analyse
BL sang
CF liquide cérébrospinal
CH composition chimique
CL classification
CS synthèse chimique
EC économie
HI histoire
IM immunologie
IP isolement et purification
ME métabolisme
PD pharmacologie
PK pharmacocinétique
PO intoxication
RE effets des radiations
SD ressources et distribution
ST normes
TO toxicité
TU usage thérapeutique
UR urine
Pharm Action: Estrogen Antagonists
Antineoplastic Agents, Hormonal
Aromatase Inhibitors
Registry Number: H3988M64PU
CAS Type 1 Name: Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-
DeCS ID: 30730
Unique ID: D017316
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1993/01/01
Date of Entry: 1992/05/19
Revision Date: 2016/07/01
Fadrozole - Preferred
Concept UI M0026296
Preferred term Fadrozole
CGS-16949A - Narrower
Concept UI M0026295
Preferred term CGS-16949A
Entry term(s) CGS16949A
Chlorhydrate de fadrozole - Narrower
Concept UI M0329304
Preferred term Chlorhydrate de fadrozole
CGS-020286A - Narrower
Concept UI M0548116
Preferred term CGS-020286A
Entry term(s) CGS020286A
FAD-286 - Narrower
Concept UI M0548117
Preferred term FAD-286
Entry term(s) FAD286



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey